Containing Costs on Infusible Drugs Starts with Vendor Alignment

Host Amanda Brummitt interviews Ali Goodwin of TrueScripts on the complexities and costs of infusible and injectable drugs in employer health plans.

Ali explains the difference between infusion and injection drugs, why site of care matters, what J‑code conversion is, and how pharmacy benefit managers, third party administrators, providers, and brokers must coordinate to steer care, capture savings, and improve patient access.

The episode also defines white/brown/clear bagging, and concludes with a practical recommendation for employers: align incentives by carving out pharmacy to an independent, transparent pharmacy benefit manager to enable better cost control and access.